MEDICENNA THERAPEUTICS CORP's ticker is MDNA and the CUSIP is 58490H107. A total of 26 filers reported holding MEDICENNA THERAPEUTICS CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,297 | -38.8% | 79,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $38,054 | -23.5% | 79,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $49,738 | +34.0% | 79,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $37,130 | -61.7% | 79,000 | -32.8% | 0.00% | -50.0% |
| Q3 2022 | $97,000 | -26.5% | 117,500 | +4.0% | 0.00% | 0.0% |
| Q2 2022 | $132,000 | +17.9% | 113,000 | +28.4% | 0.00% | 0.0% |
| Q1 2022 | $112,000 | -21.7% | 88,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $143,000 | -44.6% | 88,000 | -5.4% | 0.00% | -50.0% |
| Q3 2021 | $258,000 | -12.2% | 93,000 | -4.8% | 0.00% | 0.0% |
| Q2 2021 | $294,000 | -22.2% | 97,700 | +5.5% | 0.00% | -33.3% |
| Q1 2021 | $378,000 | -12.7% | 92,600 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $433,000 | +61.0% | 92,600 | +42.7% | 0.01% | +40.0% |
| Q3 2020 | $269,000 | +35.2% | 64,900 | +18.2% | 0.01% | +25.0% |
| Q2 2020 | $199,000 | – | 54,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 4,339,983 | $1,270,044 | 0.60% |
| Worth Venture Partners, LLC | 1,088,938 | $311,327 | 0.18% |
| Sigma Planning Corp | 634,550 | $187,129 | 0.01% |
| Verition Fund Management LLC | 555,392 | $158,787 | 0.00% |
| Hudson Bay Capital Management LP | 1,561,128 | $446,326 | 0.00% |
| McKinley Carter Wealth Services, Inc. | 79,259 | $23,374 | 0.00% |
| Warberg Asset Management LLC | 20,000 | $5,898 | 0.00% |
| Patriot Financial Group Insurance Agency, LLC | 15,000 | $4,424 | 0.00% |
| LETKO, BROSSEAU & ASSOCIATES INC | 120,000 | $35,388 | 0.00% |
| Virtu Financial LLC | 12,086 | $3 | 0.00% |